Hoth Therapeutics is a clinical-stage biopharmaceutical company focusing on developing new therapies for dermatological disorders.
Hoth Therapeutics has raised $2.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
Hoth Therapeutics is headquartered in New York, United States.
Hoth Therapeutics is a clinical-stage biopharmaceutical company focusing on developing new therapies for dermatological disorders.
Hoth Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hoth Therapeutics — Funding & Investors." VCBacked, April 1, 2026, https://www.vcbacked.co/company/hoth-therapeutics. Accessed August 17, 2026.
VCBacked. (2026). Hoth Therapeutics — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/hoth-therapeutics
{{cite web |title=Hoth Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/hoth-therapeutics |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated